Cartesian Therapeutics, Inc. (RNAC) › Shares OutstandingCartesian Therapeutics, Inc. (RNAC) — Shares OutstandingAnnual figures by fiscal year, from SEC filings.2015: 2.17M2016: 18.44M2018: 22.47M2019: 86.33M2020: 108.07M2021: 123.62M2022: 153.04M2023: 5.40M2024: 25.77M2025: 26.01M26.01M2015Shares Outstanding (shares)2025Fiscal YearShares OutstandingChange YoY202526.01M+0.9%202425.77M+377.4%20235.40M-96.5%2022153.04M+23.8%2021123.62M+14.4%2020108.07M+25.2%201986.33M+284.2%201822.47M—201618.44M+748.4%20152.17M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresDividends Per Share